References
- Inouye S., Hasegawa A., Matsuno S., Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol 1984; 20: 525–529
- SeppäläHedman K. I. Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol 1988; 3: 214–221
- Condorelli F., Stivala A., Gallo R., Musumeci E., Scatà M. C., Strano L., et al. Improvement in establishing the period of rubella virus primary infection using a mild protein denaturant. J Virol. Methods 1997; 66: 109–112
- Böttiger B., Jensen I. P. Maturation of rubella IgG avidity over time after acute rubella infection. Clin. Diagn. Virol 1997; 8: 105–111
- Soderlund M., Brown C. S, Cohen B J., Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J. Infect. Dis. 1995; 171: 710–713
- Dahlquist G. G, Ivarsson S., Lindberg B., Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood 1DDM. Diabetes 1995; 44: 408–413
- Hashido M., Inouye S., Kawana T. Differentiation of primary from nonprimary genital herpes infections by a Herpes simplex virus-specific immunoglobulin G avidity assay. J. Clin. Microbiol 1997; 35: 1766–1768
- Lazzarotto T., Spezzacatena P., Pradelli P., Abate D. A, Varani S., Landini M. P. Avidity of immunoglobulin G directed against human cytomegalovirus during primarysecondary infections in immunocompetentimmunocompromised subjects. Clin. Diagn. Lab. Immunol 1997; 4: 469–473
- Hedman K., Lappalainen M., Seppälä I., Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 1989; 4: 736–740
- Jenum P. A, Stray-Pedersen B., Gundersen A. G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxo-plasma immunoglobulin G avidity. J. Clin. Microbiol 1997; 35, 1977 1972-.
- Rulli M., Kuusisto A., Salo J., Kojola H., Simell O. Time-resolved fluorescence imaging in islet cell autoantibody quantitation. J. Immunol. Methods 1997; 208: 169–179
- Seveus L., Vaisala M., Syrjanen S., Sandberg M., Kuusisto A., Harju R., et al. Time-resolved fluorescence imaging of europium chelate label in immunohisto-chemistryin situ hybridization. Cytometry 1992; 13: 329–338
- Mukkala V. M, Helenius M., Hemmila I., Kankare J., Takalo H. Development of luminescent europium (III)terbium(III) chelates of 2,2′:6′,2′-terpyridine derivates for protein labelling. Helvetica Chim. Acta 1993; 76: 1361–1378
- Apsalons U., Bichko V. The affinities of monoclonal antibodies against core antigen of hepatitis B virus. Arch. Virol 1994; 134: 393–402
- Boullerne A. I, Petry K. G., Geffard M. Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. J. Neuroimmunol 1996; 65: 75–81